Clinical Trial Update: World Maternal Antifibrinolytic Trial_2 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a maternal antifibrinolytic intervention completed, investigating intrapartum anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• To Severe Intrapartum Anemia

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Intrapartum - Moderate and Severe Anaemia | Phase 3 | Status: COMPLETED